Substituted pyridopyrimidinones
US-2026078120-A1 · Mar 19, 2026 · US
This page is not indexed by search engines while we improve data quality.
Ketcham John Michael patents
Ketcham John Michael is listed as an inventor on 43 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ketcham John Michael |
| Total patents | 43 |
| First publication | Sep 5, 2019 |
| Latest publication | Mar 19, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Salts of sos1 inhibitors
US-2025382290-A1 · Dec 18, 2025 · US
Naphthyridine derivatives as PRC2 inhibitors
US-12421228-B2 · Sep 23, 2025 · US
SUBSTITUTED IMIDAZO[1,2-c]PYRIMIDINES AS PRC2 INHIBITORS
US-2025282787-A1 · Sep 11, 2025 · US
Sos1 inhibitors
US-2025270220-A1 · Aug 28, 2025 · US
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
US-12371435-B2 · Jul 29, 2025 · US
Imidazo[1,2-c]pyrimidine derivatives as prc2 inhibitors for treating cancer
US-2025179082-A1 · Jun 5, 2025 · US
SOS1 inhibitors
US-12304915-B2 · May 20, 2025 · US
Combination therapies
US-12280055-B2 · Apr 22, 2025 · US
Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer
US-12252493-B2 · Mar 18, 2025 · US
Recent patents
Latest publications not already listed above.
Sos1 inhibitors
US-2025059182-A1 · Feb 20, 2025 · US
Combination therapies
US-2025032497-A1 · Jan 30, 2025 · US
Substituted Quinoxalines
US-2024391882-A1 · Nov 28, 2024 · US
Kras g12d inhibitors
US-2024309020-A1 · Sep 19, 2024 · US
MTA-Cooperative PRMT5 Inhibitors
US-2024208912-A1 · Jun 27, 2024 · US
KRas G12D inhibitors
US-11964989-B2 · Apr 23, 2024 · US
Sos1 inhibitors
US-2023312482-A1 · Oct 5, 2023 · US
Kras g12d inhibitors
US-2023279025-A1 · Sep 7, 2023 · US
SOS1 inhibitors
US-11702418-B2 · Jul 18, 2023 · US
Sos1 inhibitors
US-2023137886-A1 · May 4, 2023 · US
SUBSTITUTED IMIDAZO[1,2-c]PYRIMIDINES AS PRC2 INHIBITORS
US-2023137025-A1 · May 4, 2023 · US
Sos1 inhibitors
US-2023101312-A1 · Mar 30, 2023 · US
Kras g12d inhibitors
US-2023077225-A1 · Mar 9, 2023 · US
MTA-Cooperative PRMT5 Inhibitors
US-2023054883-A1 · Feb 23, 2023 · US
Combination therapies
US-2022395507-A1 · Dec 15, 2022 · US
MTA-cooperative PRMT5 inhibitors
US-11492351-B2 · Nov 8, 2022 · US
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
US-11485738-B2 · Nov 1, 2022 · US
MTA-cooperative PRMT5 inhibitors
US-11479551-B2 · Oct 25, 2022 · US
KRas G12D inhibitors
US-11453683-B1 · Sep 27, 2022 · US
Imidazo[1,2-c]pyrimidine derivatives as prc2 inhibitors for treating cancer
US-2022274990-A1 · Sep 1, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Mirati Therapeutics Inc | 43 |
| Array Biopharma Inc | 9 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 42 |
| C07D487/04 | 27 |
| A61K31/5377 | 22 |
| C07D471/04 | 22 |
| A61K31/519 | 21 |